Company · CIK 0001703057 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
AbCellera Biologics Inc. · ABCL
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 24, 2026 PForm 4 → | Aug 24, 5:21 pm EDT | Michael R HaydenDirector | 53,613 | $10.64 | $570,442 | 1,373,397 | +4.06% | |
| Aug 18, 2026 PForm 4 → | Aug 18, 2:45 pm EDT | John S. MontalbanoDirector | 10,000 | $11.03 | $110,300 | 251,000 | +4.15% | |
| Aug 14, 2026 PForm 4 → | Aug 14, 12:04 pm EDT | Andrew BoothChief Financial Officer | 37,200 | $10.32 | $383,904 | 482,800 | +8.35% | |
| Aug 12, 2026 PForm 4 → | Aug 14, 11:50 am EDT | Michael R HaydenDirector | 46,387 | $10.37 | $481,033 | 1,319,784 | +3.64% | |
| Aug 11, 2026 GForm 4 → | Aug 13, 3:01 pm EDT | Michael R HaydenDirector | 50,000 | — | — | 1,273,397 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 AForm 4 → | Jul 6, 6:20 pm EDT | Lynn SeelyDirector | 152,207 | — | — | 152,207 | — | |
| Jul 1, 2026 AForm 4 → | Jul 6, 6:04 pm EDT | Victor SandorDirector | 152,207 | — | — | 152,207 | — |